Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas-Reference-Cited by-同舟云学术

Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas

Published:2001-05 Issue:5 Volume:158 Page:1593-1598
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Kamarashev Jivko,Burg Günter,Mingari Maria Christina,Kempf Werner,Hofbauer Günther,Dummer Reinhard

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference23 articles.

1. Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes;Agnarsson;J Am Acad Dermatol,1990

2. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma;Adachi;Am J Hematol,1994

3. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma;Dummer;Arch Dermatol,1996

4. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer;Willemze;Blood,1997

5. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells;Tian;Cell,1991

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma;Frontiers in Veterinary Science;2023-11-03

2. Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer;Frontiers in Immunology;2023-09-13

3. Hematopoietic Disorders;Atlas of Dermatopathology;2018-09-03

4. Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents;Recent Patents on Anti-Cancer Drug Discovery;2018-07-31

5. Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma;Leukemia & Lymphoma;2017-07-06